Atherosclerotic plaque regression - the role of statin therapy

Area of Science:

• Cardiology
• Vascular Biology
• Pharmacology

Background:

• Atherosclerotic plaque characteristics, including vulnerability, are increasingly understood.
• Vulnerable plaques are a primary cause of acute coronary syndromes.
• Coronary heart disease (CHD) remains a leading cause of mortality and morbidity.

Purpose of the Study:

• To review the evidence supporting atherosclerotic plaque regression.
• To discuss the role of statins in plaque regression.
• To explore imaging techniques and future therapies for managing vulnerable plaques.

Main Methods:

• Literature review of studies on atherosclerotic plaque regression.
• Analysis of the efficacy of statins in plaque regression.
• Examination of current and emerging imaging modalities for plaque assessment.
• Discussion of potential predictors and future therapeutic strategies.

Main Results:

• Growing evidence supports the feasibility of atherosclerotic plaque regression.
• Statins play a significant role in achieving plaque regression.
• Various imaging techniques allow for the monitoring of plaque changes.

Conclusions:

• Aggressive therapeutic strategies targeting plaque regression are necessary to reduce CHD burden.
• Further research into predictors and novel therapies can optimize treatment outcomes.
• Understanding plaque morphology and regression is key to managing cardiovascular risk.